Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis

NCT01490840 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
178
Enrollment
INDUSTRY
Sponsor class

Stopped The study stopped due to slow enrollment and low participant compliance.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals